On January 4, 2022 Aileron Therapeutics (Nasdaq: ALRN), a chemoprotection oncology company focused on fundamentally transforming the experience of chemotherapy for cancer patients, reported that Manuel Aivado, M.D., Ph.D., President and Chief Executive Officer, will provide a company overview and business update at the H.C. Wainwright BIOCONNECT Conference, which will be held virtually January 10th – 12th and the Emerging Growth Conference, which will be held virtually on January 5th (Press release, Aileron Therapeutics, JAN 4, 2022, View Source [SID1234598044]). Details of the upcoming Aileron presentations are as follows:
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
H.C. Wainwright BIOCONNECT Conference
Date/Time: The presentation will be available on-demand beginning on Monday, January 10, 2022 at 7:00 a.m. ET.
A recorded webcast of the presentation will be archived under the Investors and Media section of Aileron’s website at View Source for 30 days following the event.
Emerging Growth Conference
Date: Wednesday, January 5, 2022
Time: 12:45 p.m. ET
An interactive question-and-answer session with Dr. Aivado will follow the presentation.
Register here to watch the presentation.
If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available on EmergingGrowth.com.